Oracle Investment Management Inc Eye Point Pharmaceuticals, Inc. Transaction History
Oracle Investment Management Inc
- $38 Million
- Q2 2024
A detailed history of Oracle Investment Management Inc transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Oracle Investment Management Inc holds 231,857 shares of EYPT stock, worth $2.81 Million. This represents 5.31% of its overall portfolio holdings.
Number of Shares
231,857
Previous 461,857
49.8%
Holding current value
$2.81 Million
Previous $9.55 Million
78.87%
% of portfolio
5.31%
Previous 13.27%
Shares
3 transactions
Others Institutions Holding EYPT
# of Institutions
163Shares Held
58.2MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$101 Million5.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$62.7 Million1.88% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$45.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.65MShares$44.2 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$43.5 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $413M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...